LYMEPOLICYWONK: A Baker’s Dozen?—Or Is it Six of One a Half Dozen of another?
You can read our full letter to the editor here. http://www.fasebj.org/content/24/12/4632.full A snippet to fuel the fire:
“What Baker fails to tell us is that among more than 22,000 peer-reviewed articles about tick-borne diseases, there are literally hundreds that demonstrate persistent B. burgdorferi infection and failure of short-course antibiotic therapy in animal models and humans, as well as a limited number of studies showing the utility of prolonged antibiotic treatment in patients with persistent Lyme disease symptoms (3,–,10). Refusal to acknowledge this evidence and failure to provide treatment options to patients are the factors that caught the attention of the Connecticut Attorney General when he brought his antitrust lawsuit against the Infectious Diseases Society of America (IDSA) (11). It was not the science that was at issue, as Baker wrongly maintains, but rather the process employed by a powerful medical society that led to a biased and exclusionary view of Lyme disease that ultimately has harmed sick patients (12).”
You can contact Lorraine Johnson, JD, MBA at lbjohnson@lymedisease.org.
